GlassScriptPhysician profile
David Rion
NPI 1538555750
$20,615.82
in general payments reported to CMS, 2019-2025
20 companies · $4,127 in 2025
The $4,127 reported for 2025 was more than what 80% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,415 · 2020: $4,957 · 2021: $2,337 · 2022: $1,597 · 2023: $869 · 2024: $5,313 · 2025: $4,127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,659 · Food and Beverage: $4,122 · Consulting Fee: $528.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,659.08 |
| Food and Beverage | $4,122.20 |
| Consulting Fee | $528.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $13,936.83 | 2019-2025 | Avenir, Persona, Rosa |
| Moximed, INC | $1,788.04 | 2025 | Misha Knee System, Small, Left |
| Arthrex, INC. | $1,752.12 | 2020 | |
| Southtech Orthopedics | $999.97 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $889.44 | 2025 | Iovera |
| Horizon Therapeutics Plc | $460.17 | 2020-2022 | |
| Zyla Life Sciences, INC. | $209.01 | 2019-2020 | |
| Stryker Corporation | $137.25 | 2019 | |
| Ferring Pharmaceuticals INC. | $95.10 | 2019 | |
| Precision Medical Products INC. | $56.73 | 2023 | Ortho8 Cryo-Hip Brace, Ortho8 Cryo-Knee Brace |
| Smith+Nephew, INC. | $55.00 | 2022 | |
| Heraeus Medical, LLC. | $50.22 | 2025 | |
| Depuy Synthes Sales INC. | $41.45 | 2023-2025 | Orthovisc, Monovisc |
| Heron Therapeutics, INC. | $35.27 | 2025 | Zynrelef |
| Medline Industries LP | $25.56 | 2024 | Medline Industries, INC. |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $23.04 | 2023 | Gorilla |
| Sanofi-Aventis U.S. LLC | $18.50 | 2019 | |
| Djo, LLC | $14.93 | 2020 | |
| Fidia Pharma USA INC. | $14.19 | 2019 | |
| Innovation Technologies INC | $13.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Rion listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.